Brookstone Capital Management »

Urogen Pharma shares owned by Brookstone Capital Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Brookstone Capital Management from 13F filings

Historical chart of Brookstone Capital Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Brookstone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Brookstone Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $221k 6.0k 36.80

More positions owned by Brookstone Capital Management

Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Northern Lts Fd Tr Iv Brookstone Grwth (BAMG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Exch Traded Fd Tr Ii S&p500 Hdl Vol (SPHD)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Northern Lts Fd Tr Iv Broo Valu St Etf (BAMV)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Brookstone Capital Management

Top funds holding Urogen Pharma

Rtw Investments
BlackRock
Morgan Stanley
Kynam Capital Management
Leucadia National Corporation
SG Americas Securities
American Century Companies
Acorn Capital Advisors
Point72 Asset Management
Frontier Capital Management
Opaleye Management
Silverarc Capital Management
Menora Mivtachim Holdings
D. E. Shaw & Co
MPM Oncology Impact Management

View all funds holding Urogen Pharma